Esmolol for heart protection during heart attack
Part of Heart & circulation clinical trials.
This study tests if giving a fast-acting heart medication (esmolol) early through an IV can protect the heart muscle during a heart attack. It may help patients who cannot receive a standard treatment due to certain risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with a type of heart attack called ST-elevation MI within the last 8 hours.
- Your doctor chose not to give you a standard IV heart medication (metoprolol) because of risks like low blood pressure, heart failure, or other conditions.
- You must be willing to sign a consent form to take part in the study.
- You cannot have severe heart failure, a very slow heart rate (below 60 beats per minute), or low blood pressure (below 100/60).
- You cannot have asthma that is currently flaring up, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
This trial tests a medication called esmolol (a short-acting beta-blocker) to see if it can improve blood flow in tiny blood vessels (microcirculation) and help stabilize blood pressure in people with septic shock who have a fast heart rate. The goal is to see if slowing the heart rate can improve organ function and recovery.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
This study tests whether a medicine called esmolol, which slows the heart rate, can help people with septic shock (a severe infection that causes very low blood pressure) when their heart is beating too fast. Doctors will use ultrasound to make sure it's safe before giving the medicine.
This trial tests whether esmolol (a short-acting heart medicine) can help doctors identify certain heart-related problems in people with type 2 diabetes, liver scarring (cirrhosis), or specific cancers. It’s mainly about improving how heart issues are detected during ultrasound testing.
Hear when a new Coronary Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.